Advertisement

Neurochemical Research

, Volume 38, Issue 12, pp 2503–2515 | Cite as

Psychoneurochemical Investigations to Reveal Neurobiology of Memory Deficit in Epilepsy

  • Awanish Mishra
  • Rajesh Kumar Goel
Original Paper

Abstract

Pentylenetetrazole-kindling induced memory deficit has been validated in our previous study. The present study attempts a neurochemical investigation to reveal possible targets for treatment of memory deficit associated with pentylenetetrazole-kindling. Kindling was induced by administering subconvulsive dose of pentylenetetrazole (35 mg/kg; i.p.) at an interval of 48 ± 2 h. Successfully kindled animals were divided into two groups (interictal and postictal group), while non-kindled (naive) animals served as naïve group. In postictal group, animals were challenged with pentylenetetrazole (35 mg/kg) on days 5, 10, 15 and 20. Learning and memory were evaluated in all experimental groups using elevated plus maze and passive shock avoidance paradigm on days 5, 10, 15 and 20. After behavioral evaluations on day 20, all animals were sacrificed to remove their brains. Neurochemical (glutamate, GABA, norepinephrine, dopamine and serotonin) changes and acetylcholinesterase activity and total nitrite level were estimated using HPLC-FD methods and microplate reader method respectively, in discrete brain parts. The results of the neurochemical estimation demonstrated the imbalance in excitatory/inhibitory tone, reduction in monoamine level, elevated nitrosative and acetylcholinesterase activity in the cortex and hippocampus, as responsible factors for the pathobiology of learning and memory deficit in epilepsy. Restoration of these changes may be targeted for the management of memory deficit in epileptic patients.

Keywords

Pentylenetetrazole-kindling Epileptic comorbidity Learning and memory deficit Neurotransmitters Post and interictal status 

Notes

Acknowledgments

The authors would like to acknowledge the Indian Council of Medical Research, New Delhi, India for the grant of funding for research work and award of Senior Research Fellowship to Mr. Awanish Mishra (Grant No. 45/33/2010/PHA-BMS) and Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala to provide infrastructures and other facilities to carry out research work.

Conflict of interest

The authors declare that they have no conflict of interest related to this manuscript.

References

  1. 1.
    Bradford HF (1995) Glutamate, GABA and epilesy. Prog Neurobiol 47:477–511PubMedCrossRefGoogle Scholar
  2. 2.
    Gaitatzis A, Carroll K, Majeed A, Sander W (2004) The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 45:1613–1622PubMedCrossRefGoogle Scholar
  3. 3.
    LaFrance WC Jr, Kanner AM, Hermann B (2008) Psychiatric comorbidities in epilepsy. Int Rev Neurobiol 83:347–383PubMedCrossRefGoogle Scholar
  4. 4.
    Mojs E, Gajewska E, Głowacka MD, Samborski W (2007) The prevalence of cognitive and emotional disturbances in epilepsy and its consequences for therapy. Ann Acad Med Stetin 53:82–87PubMedGoogle Scholar
  5. 5.
    Hommet C, Mondon K, Camus V, De Toffol B, Constans T (2008) Epilepsy and dementia in the elderly. Dement Geriatr Cogn Disord 25:293–300PubMedCrossRefGoogle Scholar
  6. 6.
    Elger CE, Helmstaedter C, Kurthen M (2004) Chronic epilepsy and cognition. Lancet Neurol 3:663–672PubMedCrossRefGoogle Scholar
  7. 7.
    Lagae L (2006) Cognitive side effects of anti-epileptic drugs. The relevance in childhood epilepsy. Seizure 15:235–241PubMedCrossRefGoogle Scholar
  8. 8.
    Vinayan KP (2006) Epilepsy, antiepileptic drugs and educational problems. Indian Pediatr 43:l786–1794Google Scholar
  9. 9.
    Marson AG, Appleton R, Baker GA, Chadwick DW, Doughty J, Eaton B, Gamble C, Jacoby A, Shackley P, Smith DF, Tudur-Smith C, Vanoli A, Williamson PR (2007) A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. Health Technol Assess 11:1–134Google Scholar
  10. 10.
    Eddy CM, Rickards HE, Cavanna AE (2011) The cognitive impact of antiepileptic drugs. Ther Adv Neurol Disord 4:385–407PubMedCrossRefGoogle Scholar
  11. 11.
    Griffith HR, Martin R, Andrews S, LeBron Paige A, Ware J, Faught E, Welty T (2008) The safety and tolerability of galantamine in patients with epilepsy and memory difficulties. Epilepsy Behav 13:376–380PubMedCrossRefGoogle Scholar
  12. 12.
    Mishra A, Goel RK (2012) Age dependent learning and memory deficit in Pentylenetetrazol kindled mice. Eur J Pharmacol 674:315–320PubMedCrossRefGoogle Scholar
  13. 13.
    Singh D, Mishra A, Goel RK (2013) Effect of saponin fraction from Ficus religiosa on memory deficit, behavioral and biochemical impairments in pentylenetetrazol kindled mice. Epilepsy Behav 27:206–211PubMedCrossRefGoogle Scholar
  14. 14.
    Choudhary KM, Mishra A, Goel RK (2013) Ameliorative effect of Curcumin on seizure severity, depression like behavior, learning and memory deficit in post pentylenetetrazole-kindled mice. Eur J Pharmacol 704:33–40PubMedCrossRefGoogle Scholar
  15. 15.
    Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95PubMedCrossRefGoogle Scholar
  16. 16.
    Voigt JP, Morgenstern E (1986) Pentylenetetrazol kindling impairs learning in mice. Biomed Biochim Acta 49:115–120Google Scholar
  17. 17.
    Takechi K, Suemaru K, Kawasaki H, Araki H (2012) Impaired memory following repeated pentylenetetrazol treatments in kindled mice. Yakugaku Zasshi 132:179–182PubMedCrossRefGoogle Scholar
  18. 18.
    Pitkänen A, Sutula TP (2002) Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol 1:173–181PubMedCrossRefGoogle Scholar
  19. 19.
    Stefan H, Pauli E (2002) Progressive cognitive decline in epilepsy: an indication of ongoing plasticity. Prog Brain Res 135:409–417PubMedCrossRefGoogle Scholar
  20. 20.
    McNamara JO (1994) Cellular and molecular basis of epilepsy. J Neurosci 14:3413–3425PubMedGoogle Scholar
  21. 21.
    Morimoto K, Fahnestock M, Racine RJ (2004) Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 73:1–60PubMedCrossRefGoogle Scholar
  22. 22.
    Szyndler J, Maciejak P, Turzynska D, Sobolewska A, Lehner M, Taracha E, Walkowiak J, Skorzewska A, Wislowska-Stanek A, Hamed A, Bidzinski A, Plaznik A (2008) Changes in the concentration of amino acids in the hippocampus of pentylenetetrazole-kindled rats. Neurosci Lett 439:245–249PubMedCrossRefGoogle Scholar
  23. 23.
    McEntee WJ, Crook TH (1993) Glutamate: its role in learning, memory, and the aging brain. Psychopharmacology 111:391–401PubMedCrossRefGoogle Scholar
  24. 24.
    Li F, Tsien JZ (2009) Memory and the NMDA receptors. N Engl J Med 361:302–303PubMedCrossRefGoogle Scholar
  25. 25.
    Bordji K, Becerril-Ortega J, Buisson A (2011) Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer’s disease. Rev Neurosci 22:285–294PubMedGoogle Scholar
  26. 26.
    Li ST, Ju JG (2012) Functional roles of synaptic and extrasynaptic NMDA receptors in physiological and pathological neuronal activities. Curr Drug Targets 13:207–221PubMedCrossRefGoogle Scholar
  27. 27.
    Weinshenker D, Szot P (2002) The role of catecholamines in seizure susceptibility: new results using genetically engineered mice. Pharmacol Ther 94:213–233PubMedCrossRefGoogle Scholar
  28. 28.
    Izquierdo I, Medina JH (1997) Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol Learn Mem 68:285–316PubMedCrossRefGoogle Scholar
  29. 29.
    Starr MS (1996) The role of dopamine in epilepsy. Synapse 22:159–194PubMedCrossRefGoogle Scholar
  30. 30.
    Jobe PC, Dailey JW, Wernicke JF (1999) A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Crit Rev Neurobiol 13:317–356PubMedGoogle Scholar
  31. 31.
    Applegate CD, Burchfiel JL, Konkol RJ (1986) Kindling antagonism: effects of norepinephrine depletion on kindled seizure suppression after concurrent, alternate stimulation in rats. Exp Neurol 94:379–390PubMedCrossRefGoogle Scholar
  32. 32.
    Corcoran ME (1988) Characteristics of accelerated kindling after depletion of noradrenaline in adult rats. Neuropharmacology 27:1081–1084PubMedCrossRefGoogle Scholar
  33. 33.
    Racine R, Coscina DV (1979) Effects of midbrain raphe lesions or systemic p-chlorophenylalanine on the development of kindled seizures in rats. Brain Res Bull 4:1–7PubMedCrossRefGoogle Scholar
  34. 34.
    Zis AP, Nomikos GG, Brown EE, Damsma G, Fibiger HC (1992) Neurochemical effects of electrically and chemically induced seizures: an in vivo microdialysis study in the rat hippocampus. Neuropsychopharmacology 7:189–195PubMedGoogle Scholar
  35. 35.
    Chen G, Ensor CR, Bohner B (1954) A facilitation action of reserpine on the central nervous system. Proc Soc Exp Biol Med 86:507–510PubMedCrossRefGoogle Scholar
  36. 36.
    Kruk ZL, Moffett A, Scott DF (1980) Platelet monoamine oxidase activity in epilepsy. J Neurol Neurosurg Psychiatry 43:68–70PubMedCrossRefGoogle Scholar
  37. 37.
    Kumlien E, Sherif F, Ge L, Oreland L (1995) Platelet and brain GABA-transaminase and monoamine oxidase activities in patients with complex partial seizures. Epilepsy Res 20:161–170PubMedCrossRefGoogle Scholar
  38. 38.
    Sherif F, Gottfries CG, Alafuzoff I, Oreland L (1992) Brain gamma-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer’s disease. J Neural Transm Park Dis Dement Sect 4:227–240PubMedCrossRefGoogle Scholar
  39. 39.
    Szot P, Weinshenker D, White SS, Robbins CA, Rust NC, Schwartzkroin PA, Palmiter RD (1999) Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli. J Neurosci 19:10985–10992PubMedGoogle Scholar
  40. 40.
    Giorgi FS, Pizzanelli C, Biagioni F, Murri L, Fornai F (2004) The role of norepinephrine in epilepsy: from the bench to the bedside. Neurosci Biobehav Rev 28:507–524PubMedCrossRefGoogle Scholar
  41. 41.
    Murchison CF, Zhang XY, Zhang WP, Ouyang M, Lee A, Thomas SA (2004) A distinct role for norepinephrine in memory retrieval. Cell 117:131–143PubMedCrossRefGoogle Scholar
  42. 42.
    Hiramatsu M, Fujimoto N, Mori A (1982) Catecholamine level in cerebrospinal fluid of epileptics. Neurochem Res 7:1299–1305PubMedCrossRefGoogle Scholar
  43. 43.
    Szyndler J, Rok P, Maciejak P, Walkowiak J, Członkowska AI, Sienkiewicz-Jarosz H, Wisłowska A, Zienowicz M, Lehner M, Bidziński A, Kostowski W, Plaznik A (2002) Effects of pentylenetetrazol-induced kindling of seizures on rat emotional behavior and brain monoaminergic systems. Pharmacol Biochem Behav 73:851–861PubMedCrossRefGoogle Scholar
  44. 44.
    Goldstein DS, Nadi NS, Stull R, Wyler AR, Porter RJ (1988) Levels of catechols in epileptogenic and nonepileptogenic regions of the human brain. J Neurochem 50:225–229PubMedCrossRefGoogle Scholar
  45. 45.
    Devinsky O, Emoto S, Goldstein DS, Stull R, Porter RJ, Theodore WH, Nadi NS (1992) Cerebrospinal fluid and serum levels of dopa, catechols, and monoamine metabolites in patients with epilepsy. Epilepsia 33:263–270PubMedCrossRefGoogle Scholar
  46. 46.
    Wise RA (2004) Dopamine, learning and motivation. Nat Rev Neurosci 5:483–494PubMedCrossRefGoogle Scholar
  47. 47.
    Gale K (1985) Mechanisms of seizure control mediated by gamma-aminobutyric acid: role of the substantia nigra. Fed Proc 44:2414–2424PubMedGoogle Scholar
  48. 48.
    Mori A, Hiramatsu M, Namba S, Nishimoto A, Ohmoto T, Mayanagi Y, Asakura T (1987) Decreased dopamine level in the epileptic focus. Res Commun Chem Pathol Pharmacol 56:157–164PubMedGoogle Scholar
  49. 49.
    Brozoski TJ, Brown RM, Rosvold HE, Goldman PS (1979) Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205:929–932PubMedCrossRefGoogle Scholar
  50. 50.
    Swanson-Park JL, Coussens CM, Mason-Parker SE, Raymond CR, Hargreaves EL, Dragunow M, Cohen AS, Abraham WC (1999) A double dissociation within the hippocampus of dopamine D1/D5receptor and beta-adrenergic receptor contributions to the persistence of long-term potentiation. Neuroscience 92:485–497PubMedCrossRefGoogle Scholar
  51. 51.
    Dazzi L, Serra M, Porceddu ML, Sanna A, Chessa MF, Biggio G (1997) Enhancement of basal and pentylenetetrazol (PTZ)-stimulated dopamine release in the brain of freely moving rats by PTZ-induced kindling. Synapse 26:351–358PubMedCrossRefGoogle Scholar
  52. 52.
    Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083–1152PubMedCrossRefGoogle Scholar
  53. 53.
    Yan QS, Jobe PC, Cheong JH, Ko KH, Dailey JW (1994) Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy prone rats. Naunyn-Schmiedebergs Arch Pharmacol 350:149–152PubMedGoogle Scholar
  54. 54.
    Lu KT, Gean PW (1998) Endogenous serotonin inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxytryptamine 1A receptor activation. Neuroscience 86:729–737PubMedCrossRefGoogle Scholar
  55. 55.
    Fink KB, Göthert M (2007) 5-HT receptor regulation of neurotransmitter release. Pharmacol Rev 59:360–417PubMedGoogle Scholar
  56. 56.
    Browning RA, Hoffman WE, Simonton RL (1978) Changes in seizure susceptibility after intracerebral treatment with 5,7-dihydroxy-tryptamine: role of serotonergic neurones. Ann N Y Acad Sci 305:437–456PubMedCrossRefGoogle Scholar
  57. 57.
    Statnick MA, Maring-Smith ML, Clough RW, Wang C, Dailey JW, Jobe PC, Browning RA (1996) Effects of 5,7-dihydroxy-tryptamine on audiogenic seizures in genetically epilepsyprone rats. Life Sci 59:1763–1771PubMedCrossRefGoogle Scholar
  58. 58.
    Kokaia M, Kalén P, Bengzon J, Lindvall O (1989) Noradrenaline and 5-hydroxytryptamine release in the hippocampus during seizures induced by hippocampal kindling stimulation: an in vivo microdialysis study. Neuroscience 32:647–656PubMedCrossRefGoogle Scholar
  59. 59.
    Trindade-Filho EM, de Castro-Neto EF, de A Carvalho R, Lima E, Scorza FA, Amado D, Naffah-Mazzacoratti Mda G, Cavalheiro EA (2008) Serotonin depletion effects on the pilocarpine model of epilepsy. Epilepsy Res 82:194–199Google Scholar
  60. 60.
    Böhme GA, Bon C, Stutzman JM, Doble A, Blanchard JC (1991) Possible involvement of nitric oxide in long-term potentiation. Eur J Pharmacol 199:379–381PubMedCrossRefGoogle Scholar
  61. 61.
    O’Dell TJ, Hawkins RD, Kandel ER, Arancio O (1991) Tests of the roles of two diffusible substances in long term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Nat Acad Sci USA 88:11285–11289PubMedCrossRefGoogle Scholar
  62. 62.
    Huang EP (1997) Synaptic plasticity: a role for nitric oxide in LTP. Curr Biol 7:R141–R143PubMedCrossRefGoogle Scholar
  63. 63.
    Hou YC, Janczuk A, Wang PG (1999) Current trends in the development of nitric oxide donors. Curr Pharm Des 5:417–441PubMedGoogle Scholar
  64. 64.
    Penix LP, Davis W, Subramaniam S (1994) Inhibition of NO synthase increases the severity of kainic acid induced seizures in rodents. Epilepsy Res 18:177–184PubMedCrossRefGoogle Scholar
  65. 65.
    Murphy MP (1999) Nitric oxide and cell death. Biochim Biophys Acta 1411:401–414PubMedCrossRefGoogle Scholar
  66. 66.
    Ghasemi M, Dehpour AR (2011) The NMDA receptor/nitric oxide pathway: a target for the therapeutic and toxic effects of lithium. Trends Pharmacol Sci 32:420–434PubMedCrossRefGoogle Scholar
  67. 67.
    Friedman A, Behrens CJ, Heinemann U (2007) Cholinergic dysfunction in temporal lobe epilepsy. Epilepsia 48:126–130PubMedCrossRefGoogle Scholar
  68. 68.
    Weckesser M, Hufnagel A, Ziemons K, Griemeier M, Sonnenberg F, Hackländer T, Langen KJ, Holschbach Elger CE, Müller-Gärtner H (1997) Effect of partial volume correction on muscarinic cholinergic receptor imaging with single-photon emission tomography in patients with temporal lobe epilepsy. Eur J Nucl Med 24:1156–1161PubMedGoogle Scholar
  69. 69.
    Niewiadomska G, Komorowski S, Baksalerska-Pazera M (2002) Amelioration of cholinergic neurons dysfunction in aged rats depends on the continuous supply of NGF. Neurobiol Aging 23:601–613PubMedCrossRefGoogle Scholar
  70. 70.
    Turski L, Ikonomidou C, Turski WA, Bortolotto ZA, Cavalheiro EA (1989) Review: cholinergic mechanisms and epileptogenesis: the seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 3:154–171PubMedCrossRefGoogle Scholar
  71. 71.
    Gloveli T, Egorov AV, Schmitz D, Heinemann U, Muller W (1999) Carbachol induced changes in excitability and [Ca2 +] signaling in projection cells of medial entorhinal cortex layers II and III. Eur J Neurosci 11:3626–3636PubMedCrossRefGoogle Scholar
  72. 72.
    Serra M, Dazzi L, Cagetti E, Chessa MF, Pisu MG, Sanna A, Biggio G (1997) Effect of pentylenetetrazole-induced kindling on acetylcholinerelease in the hippocampus of freely moving rats. J Neurochem 68:313–318PubMedCrossRefGoogle Scholar
  73. 73.
    Beeri R, Le Novere N, Mervis R, Huberman T, Grauer E, Changeux JP, Soreq H (1997) Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase-transgenic mice. J Neurochem 69:2441–2451PubMedCrossRefGoogle Scholar
  74. 74.
    Egorov AV, Müller W (1999) Subcellular muscarinic enhancement of excitability and Ca2+-signals in CA1-dendrites in rat hippocampal slice. Neurosci Lett 261:77–80PubMedCrossRefGoogle Scholar
  75. 75.
    Czuczwar SJ (2000) Glutamate receptor antagonists as potential antiepileptic drugs. Neurol Neurochir Pol 34:41–46PubMedGoogle Scholar
  76. 76.
    Parsons CG, Stöffler A, Danysz W (2007) Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system–too little activation is bad, too much is even worse. Neuropharmacology 53:699–723PubMedCrossRefGoogle Scholar
  77. 77.
    Del-Bel EA, Oliveira PR, Oliveira JA, Mishra PK, Jobe PC, Garcia-Cairasco N (1997) Anticonvulsant and proconvulsant roles of nitric oxide in experimental epilepsy models. Braz J Med Biol Res 30:971–979PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Pharmaceutical Sciences and Drug ResearchPunjabi UniversityPatialaIndia

Personalised recommendations